Source Paper
Source Paper
Kazuaki Nishijima, Yin-Shan Ng, Lichun Zhong, John Bradley, William Schubert et al.
American Journal Of Pathology • 2007
Objective: To assess VEGF-A's neuroprotective effects and dose-dependent reduction in retinal neuron apoptosis using an ischemia-reperfusion injury model
This is a Ischemia-Reperfusion Injury Model protocol using Not explicitly stated in provided text as the model organism. The procedure involves 9 procedural steps, 2 equipment items, 2 materials. Extracted from a 2007 paper published in American Journal Of Pathology.
Model and subjects
Not explicitly stated in provided text • Not explicitly stated in provided text • unknown • Not explicitly stated in provided text • Not explicitly stated in provided text
Study window
~48 hours hands-on
Core workflow
Ischemia-reperfusion injury induction • VEGF-A exposure at varying doses • Mechanistic assessment of blood flow
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Induce ischemic injury to the retina using the ischemia-reperfusion injury model
Note: Model used to assess VEGF-A's neuroprotective effects
“we used a model of ischemia-reperfusion injury and found that VEGF-A exposure resulted in a dose-dependent reduction in retinal neuron apoptosis”
Expose retinal tissue to dose-dependent amounts of VEGF-A
Note: Dose-dependent reduction in retinal neuron apoptosis was observed
“VEGF-A exposure resulted in a dose-dependent reduction in retinal neuron apoptosis”
Measure volumetric blood flow to the retina to assess contribution to neuroprotection
Note: VEGF-A-induced volumetric blood flow may be partially responsible for neuroprotection
“VEGF-A-induced volumetric blood flow to the retina may be partially responsible for the neuroprotection”
Culture retinal tissue ex vivo to demonstrate direct neuroprotective effect independent of blood flow
Note: Direct neuroprotective effect of VEGF-A demonstrated in culture
“ex vivo retinal culture demonstrated a direct neuroprotective effect for VEGF-A”
Detect VEGF receptor-2 expression in retinal neuronal cell layers
Note: VEGFR2 expression found in several neuronal cell layers
“VEGF receptor-2 (VEGFR2) expression was detected in several neuronal cell layers of the retina”
Perform functional analyses to determine VEGFR2 involvement in retinal neuroprotection
Note: VEGFR2 shown to be involved in retinal neuroprotection
“functional analyses showed that VEGFR2 was involved in retinal neuroprotection”
Apply ischemic preconditioning 24 hours before ischemia-reperfusion injury
Note: Increased VEGF-A levels and substantially decreased apoptotic retinal cells
“Ischemic preconditioning 24 hours before ischemia-reperfusion injury increased VEGF-A levels and substantially decreased the number of apoptotic retinal cells”
Inhibit VEGF-A function during ischemic preconditioning to assess its role in adaptive response
Note: Protective effect of preconditioning was reversed by VEGF-A inhibition
“The protective effect of ischemic preconditioning was reversed after VEGF-A inhibition”
Chronically inhibit VEGF-A function in normal adult animals to assess effects on retinal ganglion cells
Note: Significant loss of retinal ganglion cells observed with no effect on vascular parameters
“chronic inhibition of VEGF-A function in normal adult animals led to a significant loss of retinal ganglion cells yet had no observable effect on several vascular parameters”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
To assess VEGF-A's neuroprotective effects and dose-dependent reduction in retinal neuron apoptosis using an ischemia-reperfusion injury model
Objective
To assess VEGF-A's neuroprotective effects and dose-dependent reduction in retinal neuron apoptosis using an ischemia-reperfusion injury model
Subjects
From paperNot explicitly stated in provided text • Not explicitly stated in provided text • unknown • Not explicitly stated in provided text • Not explicitly stated in provided text
Cohort notes
From paperAdult animals used in chronic VEGF-A inhibition studies
Ischemia-reperfusion injury induction (Not explicitly stated)
VEGF-A exposure at varying doses (Not explicitly stated)
Mechanistic assessment of blood flow (Not explicitly stated)
Ex vivo retinal culture assessment (Not explicitly stated)
Retinal neuron apoptosis (dose-dependent reduction)
From paperNot explicitly stated in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Volumetric blood flow to retina
From paperNot explicitly stated in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
VEGFR2 expression in retinal neuronal cell layers
From paperNot explicitly stated in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Number of apoptotic retinal cells
From paperNot explicitly stated in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Retinal neuron apoptosis (dose-dependent reduction)
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Volumetric blood flow to retina
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
VEGFR2 expression in retinal neuronal cell layers
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Number of apoptotic retinal cells
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
Not explicitly stated in provided text
Scoring or quantification
Quantify the primary readouts for this experiment: Retinal neuron apoptosis (dose-dependent reduction); Volumetric blood flow to retina; VEGFR2 expression in retinal neuronal cell layers; Number of apoptotic retinal cells.
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for Retinal neuron apoptosis (dose-dependent reduction), Volumetric blood flow to retina, VEGFR2 expression in retinal neuronal cell layers, Number of apoptotic retinal cells.
Source links and direct wording from the methods section for validation and deeper review.
Citation
Kazuaki Nishijima et al. (2007). Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury. American Journal Of Pathology
“”
“”
“”
“”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Gather these items before starting the experiment. Check off items as you prepare.
Not explicitly stated in provided text • Not explicitly stated • Not explicitly stated • Not explicitly stated
Not explicitly stated • Not explicitly stated • Not explicitly stated • Not explicitly stated
Not explicitly stated • Not explicitly stated • Not explicitly stated • Not explicitly stated
Not explicitly stated • Not explicitly stated • Not explicitly stated • Not explicitly stated
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Feb 28, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
9
Evidence Quotes
13
Protocol Items
4
Linked Products
0
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Feb 28, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
9
Evidence
13
Specific Products
0/0
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Feb 28, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.
What still needs work
T-Maze Reward-Searching Task
Aversive Stimulus Response Test
Heroin-Induced Reinstatement
Heroin Self-Administration